These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17259340)

  • 1. Iron and copper toxicity in diseases of aging, particularly atherosclerosis and Alzheimer's disease.
    Brewer GJ
    Exp Biol Med (Maywood); 2007 Feb; 232(2):323-35. PubMed ID: 17259340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis.
    Altamura S; Muckenthaler MU
    J Alzheimers Dis; 2009; 16(4):879-95. PubMed ID: 19387120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks of copper and iron toxicity during aging in humans.
    Brewer GJ
    Chem Res Toxicol; 2010 Feb; 23(2):319-26. PubMed ID: 19968254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risks of free copper in the body and the development of useful anticopper drugs.
    Brewer GJ
    Curr Opin Clin Nutr Metab Care; 2008 Nov; 11(6):727-32. PubMed ID: 18827576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metals in Alzheimer's and Parkinson's diseases.
    Barnham KJ; Bush AI
    Curr Opin Chem Biol; 2008 Apr; 12(2):222-8. PubMed ID: 18342639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity.
    Lopes KO; Sparks DL; Streit WJ
    Glia; 2008 Aug; 56(10):1048-60. PubMed ID: 18442088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain iron accumulation in aging and neurodegenerative disorders.
    Hagemeier J; Geurts JJ; Zivadinov R
    Expert Rev Neurother; 2012 Dec; 12(12):1467-80. PubMed ID: 23237353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease.
    Polidori MC; Griffiths HR; Mariani E; Mecocci P
    Amino Acids; 2007; 32(4):553-9. PubMed ID: 17273806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of peripheral markers of copper homeostasis in Alzheimer's disease patients: implications in aetiology and therapy.
    Rossi L; Squitti R; Calabrese L; Rotilio G; Rossini PM
    J Nutr Health Aging; 2007; 11(5):408-17. PubMed ID: 17657362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose, glycation and aging.
    Suji G; Sivakami S
    Biogerontology; 2004; 5(6):365-73. PubMed ID: 15609100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease.
    Crouch PJ; White AR; Bush AI
    FEBS J; 2007 Aug; 274(15):3775-83. PubMed ID: 17617225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal aging and Alzheimer's disease: growing problems.
    Terry RD
    Monogr Pathol; 1990; (32):41-54. PubMed ID: 2192279
    [No Abstract]   [Full Text] [Related]  

  • 13. Mapping local hippocampal changes in Alzheimer's disease and normal ageing with MRI at 3 Tesla.
    Frisoni GB; Ganzola R; Canu E; Rüb U; Pizzini FB; Alessandrini F; Zoccatelli G; Beltramello A; Caltagirone C; Thompson PM
    Brain; 2008 Dec; 131(Pt 12):3266-76. PubMed ID: 18988639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron in the brain: implications for Parkinson's and Alzheimer's diseases.
    Youdim MB
    Mt Sinai J Med; 1988 Jan; 55(1):97-101. PubMed ID: 3279308
    [No Abstract]   [Full Text] [Related]  

  • 15. Copper imbalance and oxidative stress in neurodegeneration.
    Rossi L; Arciello M; Capo C; Rotilio G
    Ital J Biochem; 2006; 55(3-4):212-21. PubMed ID: 17274527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach to the identification and quantitative elemental analysis of amyloid deposits--insights into the pathology of Alzheimer's disease.
    Rajendran R; Minqin R; Ynsa MD; Casadesus G; Smith MA; Perry G; Halliwell B; Watt F
    Biochem Biophys Res Commun; 2009 Apr; 382(1):91-5. PubMed ID: 19258010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
    Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
    Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why do Alzheimer's disease and Parkinson's disease target the same neurons?
    Eggers AE
    Med Hypotheses; 2009 Jun; 72(6):698-700. PubMed ID: 19250756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper and Alzheimer's disease.
    Donnelly PS; Xiao Z; Wedd AG
    Curr Opin Chem Biol; 2007 Apr; 11(2):128-33. PubMed ID: 17300982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Deficits in inhibitory processes in normal aging and patients with Alzheimer's disease: a review].
    Fournet N; Mosca C; Moreaud O
    Psychol Neuropsychiatr Vieil; 2007 Dec; 5(4):281-94. PubMed ID: 18048106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.